Syngene International

BSE : 539268 | NSE : SYNGENE

Industry : Pharmaceuticals | ISIN : INE398R01022 | FreeFloat : 10.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)2,430.51
Net Worth (NW)2,174.10
Intrinsic Worth (IW)4,604.61
Market Cap (MC)9,606.00
Economic Value Added-57.41
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)52.78%
IC Gross Margin (EBITDA/IC)21.55%
IC Net Margin (NPT/IC)11.92%
Knowledge Turnover (Sales/IC)0.93
Market to Intrinsic Value (MC/IW)2.09

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 115.12Rs. 240.15
26 May 2020 - Rs. 352.20
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 342.35ReduceSell
KB > 50% : Yes50 DMA : Rs. 290.80
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
S
291.10
308.30
113.20
81.30
76.00
62.00
68.20
Sep-17
S
335.20
351.60
129.90
99.60
94.40
76.90
76.20
Dec-17
C
387.70
399.30
126.20
91.20
97.70
82.00
82.00
Mar-18
C
409.10
425.70
129.10
94.90
104.40
84.50
84.50
Jun-18
C
406.00
424.80
109.50
72.20
83.10
66.20
66.20
Sep-18
C
418.60
436.80
126.70
86.80
96.80
78.30
78.30
Dec-18
C
467.10
484.40
140.60
97.70
106.80
87.00
87.00
Mar-19
C
533.90
554.70
160.00
115.90
128.70
100.10
100.10
Jun-19
C
420.90
441.40
121.10
73.70
87.10
72.00
72.00
Sep-19
C
464.60
485.20
139.20
86.60
170.10
128.10
128.10
Dec-19
C
519.10
539.10
153.50
96.50
106.70
91.80
91.80
Mar-20
C
607.30
627.80
86.90
24.60
15.30
12.02
-1.38
* C - Consolidated, S - Standalone